Related Experiment Video
Updated: Oct 25, 2025

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 14, 2011
Disseminated histoplasmosis in Peruvian non-HIV patients: an underrecognized endemic disease
Omayra Chincha1, Beatriz Bustamante2
1Departamento de Enfermedades Infecciosas, Tropicales y Dermatoloógicas, Hospital Cayetano Heredia, Lima, Perú.
Background:
Histoplasmosis is a worldwide mycosis with endemic areas throughout Latin America. Disseminated histoplasmosis (DH) has been described in Peru, but there are few reports about its clinical presentation in non-HIV patients.
Methods:
Case series was done with review of clinical and laboratory charts from Hospital Cayetano Heredia and Instituto de Medicina Tropical Alexander von Humboldt. Eight patients meet the case definition: HIV negative test and definitive diagnosis of DH (isolation of H. capsulatum in culture and/or presence of yeasts on the histopathology), between 2000-2019.
Results:
Six were men with median age of 53 years [IQR 35-63,5], most of them were farmers or merchants and with a history of being born in or traveled to the jungle. The median time of illness until diagnosis was 390 days [IQR 60-730] and in 7 out 8 cases the diagnosis was made by isolation of fungi in culture. Isolates required 11 days [IQR 10-18] to become detectable in culture. Six cases had another concomitant disease that probably caused an immunosuppression.
Conclusion:
DH form occurs rarely in apparently healthy people. In this series, men in their fifties, working in farming or merchant, with history of being born in or traveled to the jungle were the most frequent epidemiological characteristics. Culture and histopathology were used for the diagnosis but obtaining the results required several days. It is necessary the use of other faster techniques and to strengthen the clinical awareness about this disease.
Related Concept Videos
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Fungal Phylum Microsporidia

